China injectable drug delivery devices market is projected to register at CAGR of 17.5% in the forecast period of 2020 to 2027. The new market report contains data for historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027

Market Segmentation:
China Injectable Drug Delivery Devices Market, By Product Type (Formulations, Devices), Usage Pattern (Curative Care, Immunization, Other Usage Pattern), Mode of Administration (Skin, Circulatory/ Muskoskeletal, Organs, Central Nervous System), Application (Hormonal Disorders, Oncology, Autoimmune Disorders, Orphan Diseases, Others), End User (Hospitals & Clinics, Home Healthcare Settings, Research Laboratories, Pharmaceutical & Bio Technological Companies, Others), Distribution Channel (Direct Tenders, Hospital Pharmacies, Pharmacy Stores, Online Pharmacy) Industry Trends and Forecast to 2027
Some of the major factors contributing to the growth of the China injectable drug delivery devices market are:

- Rising cases of chronic diseases in the market
- Rising demand of self-injection devices in the market


Market Players:

The key market players for China injectable drug delivery devices market are listed below:

- Baxter
- BD
- Changee Medical Devices Co., Ltd
- China Meheco Group Co., Ltd
- Elcam Medical
- ELI LILLY AND COMPANY
- Gerresheimer AG
- Harbin Pharmaceutical Group Co., Ltd
- Jiangsu Delfu Medical Device Co., Ltd
- Mylan N.V.
- Novo Nordisk A/S
- Pfizer Inc.
- Sandoz International Gmbh (a subsidiary of Novartis AG)
- Sanofi
- Schott AG
- Shanghai Fosun Pharmaceutical(Group)Co., Ltd
- Shanghai General Pharmaceutical Co., Ltd
- Terumo Corporation
- West Pharmaceutical Services, Inc
- YPSOMED
- Shanghai Umitai Medical Technology Co.,Ltd.
- Hengrui Medicine